Objectives: This study aims to investigate the possible impact of hormonal changes on nasal resonance during pregnancy.
Upper respiratory tract congestion in pregnancy was first defined by McKenzie [1] near the end of the 19 th century but the etiology and pathopysiology of nasal congestion arising in pregnancy is not clear. The most commonly accepted is the estrogen theory of Toppozada et al. [2, 3] based upon biopsies obtained from nasal mucosa of women on oral contraceptives and those who are pregnant. Estrogen leads to vascular enlargement, via the cholinergic effect on nasal mucosa and increase in gland activity resulting in sinonasal symptoms occurring in pregnancy. [4, 5] Increased serum progesterone levels during pregnancy cause relaxation of smooth muscles in nasal mucosa, giving rise to vascular pooling associated with enlargement of vessels. [6] Voice produced in the larynx is modified by the supraglottic resonator and articulator structures. [7] Changes in the resonator structures can have an impact on speech resonance. [8] Obstructions in the nasal airway cause sound to be directed to the oral cavity leading to hyponasal voice, while increase in the nasal cavity volume increases nasalance scores. [9] The aim of the present study was to investigate the effect of hormonal changes on nasal resonance in pregnancy objectively by nasometer and to compare their nasalance scores with those of a normal population, as well as to evaluate nasal congestion in pregnancy subjectively by the nasal obstruction symptom evaluation (NOSE) scale.
PATIENTS AND METHODS
In this study, pregnant women visiting obstetric clinics for routine checkups between January 1 st 2013 and June 1 st 2013 were evaluated. A total of 115 pregnant women were considered as the study group. Fourteen cases with rhinologic disease (allergic rhinitis, vasomotor rhinitis, nasal polyposis, septum deviation), an active infection or who had undergone nose surgery previously were excluded from the study. Those who used antibiotics, nasal steroids and systemic steroids within the last two weeks from the time of the examination were not included in the study. One hundred one pregnant women (mean age 27.1±5.8 years; range 18 to 41 years) were finally enrolled as the study group.
All participants were thoroughly aware of the study and informed consent forms were signed. A local ethics committee approved the study (24.4.2013; 4197). The study was conducted in accordance with the principles of the Declaration of Helsinki.
Age, pregnancy week, number of pregnancies and the presence of systemic diseases were recorded. All patients underwent detailed ear, nose and throat examination, an anterior rhinoscopy and diagnostic endoscopy. Nasal symptoms were elicited, and the time of onset was recorded. Patients previously diagnosed with rhinological disease, (allergic rhinitis, vasomotor rhinitis, nasal polyp, septum deviation), those with active infections during examination or those who underwent a nose operation previously were excluded from the study. In addition, those who used antibiotics, nasal steroids or systemic steroids were excluded from the study. The severity of nasal symptoms was graded with the NOSE scale (Table 1 ) and the overall NOSE scale score was found.
The control group was 99 non-pregnant women (mean age 29.2±6.6 years; range 18 to 42 years) who were referred to the same clinic with symptoms unrelated to the nasal airways. Their ages were recorded and they underwent anterior rhinoscopy and endoscopic examination. Those with nasal pathology were excluded from the study. Their nasalance values were determined.
Whether or not the control group matched the study group in terms of age was investigated. The control and study groups were also compared with respect to NOSE and nasalance values. Patients in study groups were subdivided into first, second and third trimester. These groups were separately compared with the control group as well as against each other.
Nasalance measurements were made with the Nasometer II 6450 (Kay Elemetrics Corp., Lincoln Park,. NJ), a standard clinical device for objective evaluation of nasal problems where the patient wears a helmet and a plate connected to it is kept between the nose and mouth, which allows the nasal and oral cavities to be evaluated separately.
Patients were kept sitting in a room with low noise and the separation plate was placed perpendicular to the frontal plane of the participant's face and positioned above the upper lip. The microphone was placed approximately 5 cm away from the mouth of the patient. The Nasometer was adjusted before testing each subject. The patient was then asked to read a standard text which includes both nasal and oral sounds which was recorded in CLS signal files format (nsp.) with a computer using Pentium 3.2 processor Windows SX system and a Realtek AC 97 sound card. Data were analyzed and the mean nasalance score values were obtained. Nasalance values of all patients were recorded with a nasometer.
Statistical analysis
For statistical analysis, SPSS for Windows version 15.0 software program (SPSS Inc., Chicago, IL, USA) was used. Numerical variables were expressed as mean ± standard deviation and median (minimum-maximum) values. For categorical variables, the number and percentage was used. Whether or not the numerical variables were distributed normally was investigated using the Shapiro Wilks test. Whether or not there was a difference between two groups in terms of numerical variables was investigated by t test if parametric test hypotheses were met and by Mann-Whithey U test if these hypotheses were not met. When comparing more than two groups in terms of numerical variables, the Kruskal Wallis test was used. When a significant difference was found between groups, the groups causing the difference were determined by the Dunn test. A p level of <0.05 was considered significant.
RESULTS
The mean pregnancy was 26.9±8.8 (9-40) weeks. The number of pregnancies each woman in the study had was a mean of 2.4±1.1 (1-7) ( Table 2 ).
The mean NOSE scale score was 2.8±3. (Table 3 ).
The mean NOSE scores of the cases in third trimester were found to be statistically (Table 3 ).
In the control group, the mean nasalance values was found to be 44.69±6.38 (median 44; min.-max. 35-67) ( Table 4 ).
The study and control groups were matched for age (p=0.020). In the comparison of nasalance values between the study group and control groups, nasalance value was found to be statistically significantly lower in the study group than that in control group (p<0.001) ( Table 4 ).
In the comparison of mean nasalance values between control group and first, second and third trimester cases, the mean nasalance values in second and third trimesters were found to be statistically significantly lower than that in control group (p<0.001) ( Table 5 ).
DISCUSSION
Although nasal congestion occurring during pregnancy has long been described, it is not a well-recognized condition.
In the study of Ellegård et al., [10] it was shown that there were higher levels of congestion in women during pregnancy than the post pregnancy period and that nasal congestion increased as pregnancy progressed as proven by the comparison between early pregnancy (15-18 weeks) and late pregnancy (last month before birth). In the study of Bende and Gredmark, [11] the rate of nasal congestion was found to be 27% in the 12 th week, 37% in the 20 th week, 40% in the 39 th week and 42% in the 36 th week of pregnancy. In another study, pregnant women were compared against non-pregnant women and it was demonstrated that nasal congestion increased significantly in the third trimester. [12] Caruso et al. [13] showed that nasal respiratory epithelium is an estrogen target. Similarly Toppozada et al. [3] found histochemical changes in nasal mucosa in females using contraceptive pills. It is reported that in professional voice users some vocal symptoms can occur due to premenstrual syndrome. [14] In this study, nasalance values were found to be statistically significantly lower in the study group than that in control group (p<0.001). In the study group no statistically significant difference was found between trimesters with regard to nasalance scores. However, a decrease was observed in nasalance values as pregnancy progressed even if it was not statistically significant. In the comparison of pregnant and the control groups the second and third trimester mean nasalance values were found to be statistically significantly lower than that in the control group (p<0.001). Also, mean NOSE scores were found to be statistically significantly higher in the third trimester than that in the second trimester (p<0.001).
The limitations of this study are could not be regular follow-up of the pregnant women during the all trimesters and could not examine the nasal airlines with the objective measurements.
In conclusion, nasal congestion arises in association with the hormonal changes of pregnancy and increases as pregnancy advances, changing nasal and speech resonance. Nasal complaints are more pronounced in the third trimester than in the second and nasalance values are statistically significantly lower in pregnant women than in controls. Pregnancy leads to hyponasal voice, which is more notable especially in the third trimester. The change of the speech resonance is important especially for professional voice users who should be reminded that during pregnancy their voice will be hyponasal especially in the third trimester but will improve after delivery.
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